118 related articles for article (PubMed ID: 2341906)
1. The utility of cerebral blood flow imaging in patients with the unique syndrome of progressive dementia with motor neuron disease.
Ohnishi T; Hoshi H; Jinnouchi S; Nagamachi S; Watanabe K; Mituyama Y
J Nucl Med; 1990 May; 31(5):688-91. PubMed ID: 2341906
[TBL] [Abstract][Full Text] [Related]
2. [123I-IMP-SPECT finding of a case of presenile dementia with motor neuron disease--comparison between Alzheimer's disease, Pick's disease and presenile dementia with motor neuron disease].
Mitsuyama Y
Seishin Shinkeigaku Zasshi; 1989; 91(7):500-11. PubMed ID: 2608750
[TBL] [Abstract][Full Text] [Related]
3. Regional cerebral blood flow study with 123I-IMP in patients with degenerative dementia.
Ohnishi T; Hoshi H; Nagamachi S; Jinnouchi S; Futami S; Watanabe K; Mitsuyama Y
AJNR Am J Neuroradiol; 1991; 12(3):513-20. PubMed ID: 2058505
[TBL] [Abstract][Full Text] [Related]
4. Single photon emission computed tomography in motor neuron disease with dementia.
Sawada H; Udaka F; Kishi Y; Seriu N; Mezaki T; Kameyama M; Honda M; Tomonobu M
Neuroradiology; 1988; 30(6):577-8. PubMed ID: 3265766
[TBL] [Abstract][Full Text] [Related]
5. [Quantitative regional cerebral blood flow study with 123I-IMP in patients with dementia and in patients with poor activities of daily living].
Iwamiya T
Kaku Igaku; 1993 Nov; 30(11):1341-51. PubMed ID: 8277596
[TBL] [Abstract][Full Text] [Related]
6. Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia.
Sharp P; Gemmell H; Cherryman G; Besson J; Crawford J; Smith F
J Nucl Med; 1986 Jun; 27(6):761-8. PubMed ID: 3712090
[TBL] [Abstract][Full Text] [Related]
7. [N-isopropyl I-123 p-iodoamphetamine (IMP) brain SPECT in Alzheimer's disease].
Momose T; Nishikawa J; Kosaka N; Ohtake T; Watanabe T; Yoshikawa K; Iio M
Kaku Igaku; 1989 Sep; 26(9):1177-92. PubMed ID: 2810914
[TBL] [Abstract][Full Text] [Related]
8. 123I-N-isopropyl-amphetamine single photon emission computed tomography as a brain imaging technique in dementia.
Kaiser-Martini R; Kessler C; Strauss L; Sinn H; Kohlmeyer K
Acta Radiol Suppl; 1986; 369():460-2. PubMed ID: 2980527
[TBL] [Abstract][Full Text] [Related]
9. [Three-dimensional surface display with 123I-IMP brain perfusion imaging in patients with dementia].
Tomino Y; Tachibana H; Sugita M
Rinsho Shinkeigaku; 1994 Apr; 34(4):318-25. PubMed ID: 8026123
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional surface display using 123I-IMP in a case of motor neuron disease with dementia.
Okuda B; Kawabata K; Tachibana H; Sugita M; Fukuchi M
Jpn J Psychiatry Neurol; 1993 Sep; 47(3):599-602. PubMed ID: 8301875
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of adult Down's syndrome presenting parietal low uptake in 123I-IMP-SPECT].
Nakayasu H; Araga S; Takahashi K; Otsuki K; Murata M
Rinsho Shinkeigaku; 1991 May; 31(5):557-60. PubMed ID: 1834385
[TBL] [Abstract][Full Text] [Related]
12. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia.
Jagust WJ; Reed BR; Seab JP; Kramer JH; Budinger TF
Am J Physiol Imaging; 1989; 4(3):89-96. PubMed ID: 2789844
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of cognitive function and regional cerebral blood flow in Parkinson's disease by 123I-IMP SPECT].
Yamamoto K
Rinsho Shinkeigaku; 1992 Jan; 32(1):1-7. PubMed ID: 1628430
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of cerebral perfusion imaging with N-isopropyl-p-[123I]iodoamphetamine (IMP) in the cases of antiphospholipid syndrome].
Kato T; Nanbu I; Tohyama J; Ohba S
Kaku Igaku; 1995 Jan; 32(1):31-40. PubMed ID: 7897866
[TBL] [Abstract][Full Text] [Related]
15. SPECT and planar brain imaging in crack abuse: iodine-123-iodoamphetamine uptake and localization.
Weber DA; Franceschi D; Ivanovic M; Atkins HL; Cabahug C; Wong CT; Susskind H
J Nucl Med; 1993 Jun; 34(6):899-907. PubMed ID: 8509856
[TBL] [Abstract][Full Text] [Related]
16. [Clinical application of brain perfusion SPECT imaging to dementia].
Matsuda H
Rinsho Hoshasen; 1989 Oct; 34(11):1327-35. PubMed ID: 2601094
[TBL] [Abstract][Full Text] [Related]
17. Regional quantitative noninvasive assessment of cerebral perfusion and function with N-isopropyl-[123I]p-iodoamphetamine.
von Schulthess GK; Ketz E; Schubiger PA; Bekier A
J Nucl Med; 1985 Jan; 26(1):9-16. PubMed ID: 3965658
[TBL] [Abstract][Full Text] [Related]
18. Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT.
Hoshi H; Ohnishi T; Jinnouchi S; Futami S; Nagamachi S; Kodama T; Watanabe K; Ueda T; Wakisaka S
J Nucl Med; 1994 Jan; 35(1):44-50. PubMed ID: 8271059
[TBL] [Abstract][Full Text] [Related]
19. A comparison of two cerebral perfusion tracers, N-isopropyl I-123 p-iodoamphetamine and I-123 HIPDM, in the human.
Holman BL; Lee RG; Hill TC; Lovett RD; Lister-James J
J Nucl Med; 1984 Jan; 25(1):25-30. PubMed ID: 6610030
[TBL] [Abstract][Full Text] [Related]
20. [Cerebral blood flow pattern in progressive supranuclear palsy].
Okada K; Kobayashi S; Yamashita K; Fukuda H; Suyama N
Rinsho Shinkeigaku; 1991 Jun; 31(6):597-602. PubMed ID: 1934773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
